Silver Book Fact

A recent study demonstrated that the cost of treating cardiovascular disease could rise by 64% to 84% by 2025.

Steinwachs, Donald M., Ruth L. Collins-Nakai, Lawrence H. Cohn, Arthur Garson, Jr., and Michael J. Wolk. The Future of Cardiology: Utilization and costs of care. J Am Coll Cardiol. 2000; 35(4): 1092-9. https://www.google.com/search?q=The+Future+of+Cardiology%3A+Utilization+and+costs+of+care&rlz=1C1GGRV_enUS751US751&oq=The+Future+of+Cardiology%3A+Utilization+and+costs+of+care&aqs=chrome..69i57j69i60j69i64l2.624j0j4&sourceid=chrome&ie=UTF-8

Reference

Title
The Future of Cardiology: Utilization and costs of care
Publication
J Am Coll Cardiol
Publication Date
2000
Authors
Steinwachs, Donald M., Ruth L. Collins-Nakai, Lawrence H. Cohn, Arthur Garson, Jr., and Michael J. Wolk
Volume & Issue
Volume 35, Issue 4
Pages
1092-9
URL
Read Full Resource

Categories

  • Cost of Disease
  • Future Economic Burden

Related Facts

  • Average age at death from stroke, 2002
    In 2002, the mean age at death from stroke was 79.6 years.  
  • Atrial fibrillation costs
    Around 73% of total U.S. atrial fibrillation costs are for inpatient expenses.  
  • In 2009, there were 12,826,000 physician office visits, 639,000 emergency department visits, and 589,000 outpatient department visits with a primary diagnosis of coronary heart disease.  
  • Between 2.7 and 6.1 million Americans have AFib.  
  • Annual cost of treating privately insured patients for AFib
    The annual cost of treating privately insured patients for atrial fibrillation (AF) is $12,350 per patient— approximately 5 times greater than treating patients without AF.